Treatment differences were determined for olmesartan medoxomil plus hydrochlorothiazide versus olmesartan medoxomil (C vs A) and for olmesartan medoxomil plus hydrochlorothiazide versus ...

A total of 2306 patients were enrolled in the initial open-label phase of the study. Of these, 627 patients who showed a suboptimal response after 8 weeks of treatment with olmesartan medoxomil 20 ...